AR024441A1
N-pyrazole a 2a receptor agonists
Abstract
Compounds of 2-adenosine N-pyrazole having the formula (1) and methods for the use of the compounds as agonists of the A2A receptor to stimulate mammalian coronary vasodilation for therapeutic purposes and for purposes of deforming images of the heart.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
62 members in 27 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 33818599 | United States of America | A | |
| 33818599 | United States of America | A | |
| 09338185 | – | – | – |
| US19990338185 | – | – | – |
Members62
| Document | Office | Kind | |
|---|---|---|---|
| CA2377746A1 | Canada | A1 | |
| WO0078779A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7132400A | Australia | A | |
| WO0078779A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20016350D0 | Norway | D0 | |
| NO20016350L | Norway | L | |
| EP1189916A2 | European Patent Office (EPO) | A2 | |
| KR20020028910A | Republic of Korea | A | |
| US6403567B1 | United States of America | B1 | |
| MXPA01013325A | Mexico | A | |
| CN1358191A | China | A | |
| IL147198D0 | Israel | D0 | |
| TR200200588T2 | Türkiye | T2 | |
| AR024441A1This record | Argentina | A1 | |
| HK1044952A1 | Hong Kong, China | A1 | |
| JP2003506461A | Japan | A | |
| AU760806B2 | Australia | B2 | |
| US6642210B1 | United States of America | B1 | |
| ZA200200301B | South Africa | B | |
| EP1189916B1 | European Patent Office (EPO) | B1 | |
| AT256141T | Austria | T | |
| ATE256141T1 | Austria | T1 | |
| DE60007127D1 | Germany | D1 | |
| BR0011856A | Brazil | A | |
| US2004038928A1 | United States of America | A1 | |
| DK1189916T3 | Denmark | T3 | |
| PT1189916E | Portugal | E | |
| NZ516334A | New Zealand | A | |
| ES2209974T3 | Spain | T3 | |
| DE60007127T2 | Germany | T2 | |
| CN1167709C | China | C | |
| KR100463300B1 | Republic of Korea | B1 | |
| HK1044952B | Hong Kong, China | B | |
| TWI230161B | Taiwan Province of China | B | |
| US2006052332A1 | United States of America | A1 | |
| IL147198A | Israel | A | |
| NO322457B1 | Norway | B1 | |
| US7144872B2 | United States of America | B2 | |
| US7183264B2 | United States of America | B2 | |
| CA2377746C | Canada | C | |
| US2007203090A1 | United States of America | A1 | |
| US7655637B2 | United States of America | B2 | |
| US2010160620A1 | United States of America | A1 | |
| NO2011002I1 | Norway | I1 | |
| FR11C0004I1 | France | I1 | |
| LU91785I2 | Luxembourg | I2 | |
| DE122011000010I1 | Germany | I1 | |
| US2011144320A1 | United States of America | A1 | |
| JP4727880B2 | Japan | B2 | |
| CY2011002I1 | Cyprus | I1 | |
| CY2011002I2 | Cyprus | I2 | |
| FR11C0004I2 | France | I2 | |
| US8278435B2 | United States of America | B2 | |
| NO2011002I2 | Norway | I2 | |
| US2013058866A1 | United States of America | A1 | |
| US8569260B2 | United States of America | B2 | |
| US2014073596A1 | United States of America | A1 | |
| BR0011856B1 | Brazil | B1 | |
| US9045519B2 | United States of America | B2 | |
| USRE47351E | United States of America | E | |
| BE2011C004I2 | Belgium | I2 | |
| BRPI0011856B8 | Brazil | B8 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Grant, registrationFG | FG |
Numbers
- Publication, DOCDB
- 024441
- Publication, EPODOC
- AR024441
- Application
- 103123
- Application, DOCDB
- P000103123
- Application, EPODOC
- AR2000P103123
Titles2
- Spanish
- AGONISTAS DEL RECEPTOR A2A N-PIRAZOL, COMPOSICIONES FARMACEUTICAS Y EL USO DE LOS MISMOS PARA PREPARAR UN MEDICAMENTO.
- English
- A2A N-PIRAZOL RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THEM TO PREPARE A MEDICINAL PRODUCT.
Classification
- CPC, 9
- C07H19/16
- C07D473/34
- A61P29/00
- A61P43/00
- A61P7/00
- A61P7/02
- A61P9/00
- A61P9/08
- A61P9/10
- IPC, 9
- C07H19 167
- A61K31 7076
- A61P7 00
- A61P7 02
- A61P9 00
- A61P9 10
- A61P29 00
- A61P43 00
- C07H19 16